Some Positive Takeaways from 2023 for 2024
| By Cecilia Prieto | 0 Comentarios

What a difference one quarter, let alone one year, can make. Markets entered 2023 battered and bruised. A war in Ukraine and a war on inflation threatened to wreck the global economy. Cracks emerged as a succession of banks (Silicon Valley, Signature, First Republic, Credit Suisse) failed. In keeping with recent history, Congress took us to the precipice before agreeing to more spending. Tragically, another front has opened in the battle against the axis of Russia/Iran/China. Yet, notwithstanding signs of economic deceleration, inflation appears headed south while employment remains steady. Remarkably, the odds that the Federal Reserve pulls off a soft landing have grown; as Chair Powell noted in his most recent testimony: “so far, so good”.
Merger Arbitrage concluded the year on a strong note as Pfizer successfully completed its acquisition of Seagen (SGEN-NASDAQ) for $43 billion in cash. This followed a comprehensive second request process conducted by the U.S. Federal Trade Commission (FTC). Additionally, Bristol-Myers received U.S. antitrust approval in Phase 1 for its acquisition of the targeted oncology company, Mirati Therapeutics (MRTX-NASDAQ), contributing to a positive antitrust sentiment. Deal spreads, including those for Capri Holdings (CPRI-NYSE), Albertsons (ACI-NYSE), and Amedisys (AMED-NASDAQ) among others, firmed in response. Global M&A activity reached $2.9 trillion, marking a 17% decrease compared to 2022. However, the U.S. market remained robust with $1.4 trillion in announced deals, maintaining a level comparable to 2022.
Worldwide M&A totaled $2.9 trillion in 2023, a decrease of 17% compared to 2022 activity. However, fourth quarter deal making increased 23% sequentially compared to third quarter 2023, an encouraging sign that deal making may be recovering. The US remained a bright spot for deal activity with deal volume of $1.4 trillion, a decline of about 5% and accounting for 47% of worldwide M&A (compared to 42% in 2022.) Energy & Power was the most active sector with deal volume that totalled $502 billion and accounted for 17% of overall value. Industrials, Technology and Healthcare M&A each accounted for 13% of total M&A in 2023. Private Equity acquisitions totalled $566 billion and accounted for 20% of total deal activity. Despite PE deal volume declining 30% compared to 2022, it was still the sixth largest year on record for PE acquisitions.
Reflecting on a volatile year in the convertible market, we have some positive takeaways. Issuance returned to pre-pandemic levels at relatively attractive terms. We expect the pace of issuance to accelerate in 2024 as companies face a maturity wall that must be refinanced. We expect the allure of relatively lower interest rates in convertibles will bring many more companies to our market offering continued asymmetrical return opportunities. Additionally, convertibles that were issued at unattractive terms at market highs in 2021 have generally found bond floor and some offer a compelling yield to maturity. Companies that can have been repurchasing these bonds in an accretive transaction, or refinancing them by issuing converts with a more attractive profile. We expect this trend to continue in 2024 and continue to look for opportunities in this segment of the market.
Opinion article by Michael Gabelli, managing director at Gabelli & Partners


















